Document:

REGISTRATION
RIGHTS AGREEMENT

 

This
REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of February 22, 2017 (the “Execution Date”),
is entered into by and between Rich Pharmaceuticals, Inc., a Nevada corporation with its principal executive office at 9595 Wilshire
Boulevard, Suite 900, Beverly Hills, CA 90212 (the “Company”), and GHS Investments LLC, a Nevada limited liability
company, with offices at 200 Stonehinge Lane, Suite 3, Carle Place, NY 11514. (the “Investor”).

 

 

RECITALS:

 

WHEREAS,
pursuant to the Equity Financing Agreement entered into by and between the Company and the Investor of this even date (the “Equity
Financing Agreement”), the Company has agreed to issue and sell to the Investor an indeterminate number of shares of
the Company’s common stock, par value $0.001 per share (the “Common Stock”), up to an aggregate purchase
price of Two Million Dollars ($2,000,000);

 

WHEREAS,
as an inducement to the Investors to execute and deliver the Equity Financing Agreement, the Company has agreed to provide certain
registration rights under the Securities Act of 1933, as amended, and the rules and
regulations thereunder, or any similar successor statute (collectively, the “1933 Act”), and applicable state
securities laws, with respect to the shares of Common Stock issuable pursuant to the Equity Financing Agreement.

 

NOW
THEREFORE, in consideration of the foregoing promises and the mutual covenants contained hereinafter and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

 

SECTION
I

DEFINITIONS

 

As
used in this Agreement, the following terms shall have the following meanings: “Execution Date” shall have
the meaning set forth in the preambles.

“Investor”
shall have the meaning set forth in the preambles.

 

“Person”
means a corporation, a limited liability company, an association, a partnership, an organization, a business, an individual, a
governmental or political subdivision thereof or a governmental agency.

 

“Potential
Material Event” means any of the following: (i) the possession by the Company of material information not ripe for disclosure
in the Registration Statement, which shall be evidenced by determinations in good faith by the Board of Directors of the Company
that disclosure of such information in the Registration Statement would be detrimental to the business and affairs of the Company,
or (ii) any material engagement or activity by the Company which would, in the good faith determination of the Board of Directors
of the Company, be adversely affected by disclosure in the Registration Statement at such time, which determination shall be accompanied
by a good faith determination by the Board of Directors of the Company that the Registration Statement would be materially misleading
absent the inclusion of such information.

    	 	1	 

    	 	 	 

    

“Register,”
“Registered,” and “Registration” refer to the Registration effected by preparing and filing
one (1) or more Registration Statements in compliance with the 1933 Act and pursuant to Rule 415 under the 1933 Act or any successor
rule providing for offering securities on a continuous basis (“Rule 415”), and the declaration or ordering of effectiveness
of such Registration Statement(s) by the United States Securities and Exchange Commission (the “SEC”).

 

“Registrable
Securities” means (i) the shares of Common Stock issued or issuable pursuant to the Equity Financing Agreement, and
(ii) any shares of capital stock issued or issuable with respect to such shares of Common
Stock, if any, as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise,
which have not been (x) included in the Registration Statement that has been declared effective by the SEC, or (y) sold under
circumstances meeting all of the applicable conditions of Rule 144 (or any similar provision then in force) under the 1933 Act,
and (iii) the Commitment Shares.

 

“Registration
Statement” means the registration statement of the Company filed under the 1933 Act covering the Registrable Securities
excluding any Form S-8 registration statement or amendment thereto.

 

“Registered
Offering Transaction Documents” shall mean this Agreement and the Equity Financing Agreement between the Company and
the Investor as of the date hereof.

 

All
capitalized terms used in this Agreement and not otherwise defined herein shall have the same meaning ascribed to them as in the
Equity Financing Agreement.

 

SECTION
II

REGISTRATION

 

2.1              
The Company shall, within thirty (30) calendar
days upon the date of execution of this Agreement, use its commercially reasonable efforts to file with the SEC a Registration
Statement or Registration Statements (as is necessary) on Form S-1 (or, if such form is unavailable for such a registration, on
such other form as is available for such registration), covering the resale of all of the Registrable Securities, which Registration
Statement(s) shall state that, in accordance with Rule 416 promulgated under the 1933 Act, such Registration Statement also covers
such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock dividends or similar
transactions. The Company shall initially register for resale all of the Registrable Securities which would be issuable on the
date preceding the filing of the Registration Statement based on the closing bid price of the Company’s Common Stock on
such date and the amount reasonably calculated that represents Common Stock issuable to other parties as set forth in the Equity
Financing Agreement except to the extent that the SEC requires the share amount to be reduced as a condition of effectiveness.
The Registration Statement shall be prepared by Company’s legal counsel and shall be reviewed by Investor’s legal
counsel

 

2.2              
The Company shall use all commercially reasonable
efforts to have the Registration Statement(s) declared effective by the SEC within thirty (30) calendar days, but no more than
ninety (90) calendar days after the Company has filed the registration statement.

 

2.3              
The Company agrees not to include any other securities
in the Registration Statement covering the Registrable Securities without Investor’s prior written consent which Investor
may withhold in its sole discretion. Furthermore, the Company agrees that it will not file any other Registration Statement for
other securities, until thirty calendar days after the Registration Statement for the Registrable Securities is declared effective
by the SEC.

    	 	2	 

    	 	 	 

    

 

2.4              
Notwithstanding the registration obligations
set forth in this Section 2.1, if the staff of the SEC (the “Staff”) or the SEC informs the Company that all
of the unregistered Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary
offering on a single Registration Statement, the Company agrees to promptly (i) inform each of the holders thereof and use its
commercially reasonable efforts to file amendments to the Registration Statement as required by the SEC and/or (ii) withdraw the
Registration Statement and file a new registration statement (the “New Registration Statement”), in either
case covering the maximum number of Registrable Securities permitted to be registered by the SEC, on Form S-1 to register for
resale the Registrable Securities as a secondary offering. If the Company amends the Registration Statement or files a New Registration
Statement, as the case may be, under clauses (i) or (ii) above, the Company will use its commercially reasonable efforts to file
with the SEC, as promptly as allowed by the Staff or SEC, one or more registration statements on Form S-1 to register for resale
those Registrable Securities that were not registered for resale on the Registration Statement, as amended, or the New Registration
Statement (each, an “Additional Registration Statement”).

 

SECTION
III

RELATED
OBLIGATIONS

 

At
such time as the Company is obligated to prepare and file the Registration Statement with the SEC pursuant to Section 2, the Company
will affect the registration of the Registrable Securities in accordance with the intended method of disposition thereof and,
with respect thereto, the Company shall have the following obligations:

 

3.1              
The Company shall use all commercially reasonable
efforts to cause such Registration Statement relating to the Registrable Securities to become effective and shall keep such Registration
Statement effective until the earlier to occur of the date on which (A) the Investor shall have sold all the Registrable Securities;
or (B) the Investor has no right to acquire any additional shares of Common Stock under the Equity Financing Agreement (the “Registration
Period”). The Registration Statement (including any amendments or supplements thereto and prospectuses contained therein)
shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary
to make the statements therein, in light of the circumstances in which they were made, not misleading. The Company shall use all
commercially reasonable efforts to respond to all SEC comments within ten (10) business days from receipt of such comments by
the Company. The Company shall use all commercially reasonable efforts to cause the Registration Statement relating to the Registrable
Securities to become effective no later than three (3) business days after notice from the SEC that the Registration Statement
may be declared effective. The Investor agrees to provide all information which is required by law to provide to the Company,
including the intended method of disposition of the Registrable Securities, and the Company’s obligations set forth above
shall be conditioned on the receipt of such information.

 

3.2              
The Company shall prepare and file with the SEC
such amendments (including post- effective amendments) and supplements to the Registration Statement and the prospectus used in
connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the 1933 Act,
as may be necessary to keep such Registration Statement effective during the Registration Period, and, during such period, comply
with the provisions of the 1933 Act with respect to the disposition of all Registrable Securities of the Company covered by such
Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the
intended methods of disposition by the Investor thereof as set forth in such Registration Statement. In the event the number of
shares of Common Stock covered by the Registration Statement filed pursuant to this Agreement is at any time insufficient to cover
all of the Registrable Securities, the Company shall amend such Registration Statement, or file a new Registration Statement (on
the short

    	 	3	 

    	 	 	 

    

form
available therefor, if applicable), or both, so as to cover all of the Registrable Securities, in each case, as soon as practicable,
but in any event within thirty (30) calendar days after the necessity therefor arises (based on the then Purchase Price of the
Common Stock and other relevant factors on which the Company reasonably elects to rely), assuming the Company has sufficient authorized
shares at that time, and if it does not, within thirty (30) calendar days after such shares are authorized. The Company shall
use commercially reasonable efforts to cause such amendment and/or new Registration Statement to become effective as soon as practicable
following the filing thereof.

 

3.3              
The Company shall make available to the Investor
whose Registrable Securities are included in any Registration Statement and its legal counsel without charge (i) promptly after
the same is prepared and filed with the SEC at least one (1) copy of such Registration Statement and any amendment(s) thereto,
including financial statements and schedules, all documents incorporated therein by reference and all exhibits, the prospectus
included in such Registration Statement (including each preliminary prospectus) and, with regards to such Registration Statement(s),
any correspondence by or on behalf of the Company to the SEC or the staff of the SEC and any correspondence from the SEC or the
staff of the SEC to the Company or its representatives; (ii) upon the effectiveness of any Registration Statement, the Company
shall make available copies of the prospectus, via EDGAR, included in such Registration Statement and all amendments and supplements
thereto; and (iii) such other documents, including copies of any preliminary or final prospectus, as the Investor may reasonably
request from time to time to facilitate the disposition of the Registrable Securities.

 

3.4              
The Company shall use commercially reasonable
efforts to (i) register and qualify the Registrable Securities covered by the Registration Statement under such other securities
or “blue sky” laws of such states in the United States as the Investor reasonably requests; (ii) prepare and file
in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations and qualifications
as may be necessary to maintain the effectiveness thereof during the Registration Period; (iii) take such other actions as may
be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions;
provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to
do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3.4, or (y) subject itself
to general taxation in any such jurisdiction. The Company shall promptly notify the Investor who holds Registrable Securities
of the receipt by the Company of any notification with respect to the suspension of the registration or qualification of any of
the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction in the United States
or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.

 

3.5              
As promptly as practicable after becoming aware
of such event, the Company shall notify Investor in writing of the happening of any event as a result of which the prospectus
included in the Registration Statement, as then in effect, includes an untrue statement of a material fact or omission to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading (“Registration Default”) and use all diligent efforts to promptly prepare
a supplement or amendment to such Registration Statement and take any other necessary steps to cure the Registration Default (which,
if such Registration Statement is on Form S-3, may consist of a document to be filed by the Company with the SEC pursuant to Section
13(a), 13(c), 14 or 15(d) of the 1934 Act (as defined below) and to be incorporated by reference in the prospectus) to correct
such untrue statement or omission, and make available copies of such supplement or amendment to the Investor. The Company shall
also promptly notify the Investor (i) when a prospectus or any prospectus supplement or post-effective amendment has been filed,
and when the Registration Statement or any post-effective amendment has become effective (the Company will prepare notification
of such effectiveness which shall be delivered to the Investor on the same day of such effectiveness and

    	 	4	 

    	 	 	 

    

by
overnight mail), additionally, the Company will promptly provide to the Investor, a copy of the effectiveness order prepared by
the SEC once it is received by the Company; (ii) of any request by the SEC for amendments or supplements to the Registration Statement
or related prospectus or related information, (iii) of the Company’s reasonable determination that a post-effective amendment
to the Registration Statement would be appropriate, (iv) in the event the Registration Statement is no longer effective, or (v)
if the Registration Statement is stale as a result of the Company’s failure to timely file its financials or otherwise

 

3.6              
The Company shall use all commercially reasonable
efforts to prevent the issuance of any stop order or other suspension of effectiveness of the Registration Statement, or the suspension
of the qualification of any of the Registrable Securities for sale in any jurisdiction and, if such an order or
suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify
the Investor holding Registrable Securities being sold of the issuance of such order and the resolution thereof or its receipt
of actual notice of the initiation or threat of any proceeding concerning the effectiveness of the registration statement.

 

3.7              
The Company shall permit the Investor and one
(1) legal counsel, designated by the Investor, to review and comment upon the Registration Statement and all amendments and supplements
thereto at least one (1) calendar day prior to their filing with the SEC. However, any postponement of a filing of a Registration
Statement or any postponement of a request for acceleration or any postponement of the effective date or effectiveness of a Registration
Statement by written request of the Investor (collectively, the “Investor’s Delay”) shall not act to
trigger any penalty of any kind, or any cash amount due or any in-kind amount due the Investor from the Company under any and
all agreements of any nature or kind between the Company and the Investor. The event(s) of an Investor’s Delay shall act
to suspend all obligations of any kind or nature of the Company under any and all agreements of any nature or kind between the
Company and the Investor.

 

3.8              
At the request of the Investor, the Company’s
counsel shall furnish to the Investor, within three (3) business days, an opinion letter confirming the effectiveness of the registration
statement. Such opinion letter shall be issued as of the date of the effectiveness of the registration statement, in a form suitable
to the Investor.

 

3.9              
The Company shall hold in confidence and not
make any disclosure of information concerning the Investor unless (i) disclosure of such information is necessary to comply with
federal or state securities laws, (ii) the disclosure of such information is necessary to avoid or correct a misstatement or omission
in any Registration Statement, or (iii) the release of such information is ordered pursuant to a subpoena or other final, non-appealable
order from a court or governmental body of competent jurisdiction. The Company agrees that it shall, upon learning that disclosure
of such information concerning the Investor is sought in or by a court or governmental body of competent jurisdiction or through
other means, give prompt written notice to the Investor and allow the Investor, at the Investor’s expense, to undertake
appropriate action to prevent disclosure of, or to obtain a protective order covering such information.

 

3.10          
The Company shall use all commercially reasonable
efforts to maintain designation and quotation of all the Registrable Securities covered by any Registration Statement on the Principal
Market. If, despite the Company’s commercially reasonable efforts, the Company is unsuccessful in satisfying the preceding
sentence, it shall use commercially reasonable efforts to cause all the Registrable Securities covered by any Registration Statement
to be listed on each other national securities exchange and automated quotation system, if any, on which securities of the same
class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted
under the rules of such

    	 	5	 

    	 	 	 

    

exchange
or system. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3.10.

 

3.11          
The Company shall cooperate with the Investor
to facilitate the prompt preparation and delivery of certificates representing the Registrable Securities to be offered pursuant
to the Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the
Investor may reasonably request (and after any sales of such Registrable Securities by the Investor, such certificates not bearing
any restrictive legend).

 

3.12          
The Company shall provide a transfer agent for
all the Registrable Securities not later than the effective date of the first Registration Statement filed pursuant hereto.

 

3.13          
If requested by the Investor, the Company shall
(i) as soon as reasonably practical incorporate in a prospectus supplement or post-effective amendment such information as the
Investor reasonably determines should be included therein relating to the sale and distribution of Registrable Securities, including,
without limitation, information with respect to the offering of the Registrable Securities to be sold in such offering; (ii) make
all required filings of such prospectus supplement or post- effective amendment as soon as reasonably possible after being notified
of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or make amendments
to any Registration Statement if reasonably requested by the Investor.

 

3.14          
The Company shall use all commercially reasonable
efforts to cause the Registrable Securities covered by the applicable Registration Statement to be registered with or approved
by such other governmental agencies or authorities as may be necessary to facilitate the disposition of such Registrable Securities.

 

3.15          
The Company shall otherwise use all commercially
reasonable efforts to comply with all applicable rules and regulations of the SEC in connection with any registration hereunder.

 

3.16          
Within three (3) business day after the Registration
Statement which includes Registrable Securities is declared effective by the SEC, the Company shall deliver to the transfer agent
for such Registrable Securities, with copies to the Investor, confirmation that such Registration Statement has been declared
effective by the SEC.

 

3.17          
The Company shall take all other reasonable actions
necessary to expedite and facilitate disposition by the Investor of Registrable Securities pursuant to the Registration Statement.

 

SECTION
IV

OBLIGATIONS
OF THE INVESTOR

 

4.1              
At least five (5) calendar days prior to the
first anticipated filing date of the Registration Statement, the Company shall notify the Investor in writing of the information
the Company requires from the Investor for the Registration Statement. It shall be a condition precedent to the obligations of
the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities and the Investor
agrees to furnish to the Company that information regarding itself, the Registrable Securities and the intended method of disposition
of the Registrable Securities as shall reasonably be required to effect the registration of such Registrable Securities and the
Investor shall execute such documents in connection with such registration as the Company may reasonably request. The Investor
covenants and agrees that, in connection with any sale of Registrable Securities by it pursuant to the Registration Statement,
it shall comply with the “Plan of Distribution” section of the then current prospectus relating to such Registration
Statement.

    	 	6	 

    	 	 	 

    

 

4.2              
The Investor, by its acceptance of the Registrable
Securities, agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and
filing of any Registration Statement hereunder, unless the Investor has notified the Company in writing of an election to exclude
all of the Investor’s Registrable Securities from such Registration Statement.

 

4.3              
The Investor agrees that, upon receipt of written
notice from the Company of the happening of any event of the kind described in Section 3.6 or the first sentence of 3.5, the Investor
will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement(s) covering such Registrable
Securities until the Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by Section
3.6 or the first sentence of 3.5.

 

SECTION
V

EXPENSES
OF REGISTRATION

 

All
legal expenses, other than underwriting discounts and commissions and other than as set forth in the Equity Financing Agreement,
incurred in connection with registrations including comments, filings or qualifications pursuant to Sections 2 and 3, including,
without limitation, all registration, listing and qualifications fees, and printing fees shall be paid by the Company.

 

SECTION
VI

INDEMNIFICATION

 

In
the event any Registrable Securities are included in the Registration Statement under this Agreement:

 

6.1              
To the fullest extent permitted by law, the Company,
under this Agreement, will, and hereby does, indemnify, hold harmless and defend the Investor who holds Registrable Securities,
the directors, officers, partners, employees, counsel, agents, representatives of, and each Person, if any, who controls, any
Investor within the meaning of the 1933 Act or the Securities Exchange Act of 1934, as amended (the “1934 Act”)
(each, an “Indemnified Person”), against any losses, claims, damages, liabilities, judgments, fines, penalties,
charges, costs, attorneys’ fees, amounts paid in settlement or expenses, joint or several (collectively, “Claims”),
incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken
from the foregoing by or before any court or governmental, administrative or other regulatory agency, body or the SEC, whether
pending or threatened, whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”),
to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in
respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in the
Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of the
offering under the securities or other “blue sky” laws of any jurisdiction in which the Investor has requested in
writing that the Company register or qualify the Shares (“Blue Sky Filing”), or the omission or alleged omission
to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which the statements therein were made, not misleading, (ii) any untrue statement or alleged untrue statement of a material
fact contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto
with the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein,
in light of the circumstances under which the statements therein were made, not misleading, or (iii) any violation or alleged
violation by the Company of the 1933 Act, the 1934 Act, any other law, including, without limitation, any state securities law,
or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities pursuant to the Registration
Statement (the matters in the foregoing clauses (I)

    	 	7	 

    	 	 	 

    

through
(iii) being, collectively, “Violations”). Subject to the restrictions set forth in Section 6.3 the Company
shall reimburse the Investor and each such controlling person, promptly as such expenses are incurred and are due and payable,
for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending any
such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section
6.1: (I) shall not apply to a Claim arising out of or based upon a Violation which is due to the inclusion in the Registration
Statement of the information furnished to the Company by any Indemnified Person expressly for use in connection with the preparation
of the Registration Statement or any such amendment thereof or supplement thereto; (ii) shall not be available to the extent such
Claim is based on (a) a failure of the Investor to deliver or to cause to be delivered the prospectus made available by the Company
or (b) the Indemnified Person’s use of an incorrect prospectus despite being promptly advised in advance by the Company
in writing not to use such incorrect prospectus; (iii) any claims based on the manner of sale of the Registrable Securities by
the Investor or of the Investor’s failure to register as a dealer under applicable securities laws; (iv) any omission of
the Investor to notify the Company of any material fact that should be stated in the Registration Statement or prospectus relating
to the Investor or the manner of sale; and (v) any amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of the Company, which consent shall not be unreasonably withheld. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the resale of
the Registrable Securities by the Investor pursuant to the Registration Statement.

 

6.2              
In connection with any Registration Statement
in which Investor is participating, the Investor agrees to severally and jointly indemnify, hold harmless and defend, to the same
extent and in the same manner as is set forth in Section 6.1, the Company, each of its directors, each of its officers who signs
the Registration Statement, each Person, if any, who controls the Company within the meaning of the 1933 Act or the 1934 Act and
the Company’s agents (collectively and together with an Indemnified Person, an “Indemnified Party”),
against any Claim or Indemnified Damages to which any of them may become subject, under the 1933 Act, the 1934 Act or otherwise,
insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case to the extent, and only
to the extent, that such Violation is due to the inclusion in the Registration Statement of the written information furnished
to the Company by the Investor expressly for use in connection with such Registration Statement; and, subject to Section 6.3,
the Investor will reimburse any legal or other expenses reasonably incurred by them in connection with investigating or defending
any such Claim; provided, however, that the indemnity agreement contained in this Section 6.2 and the agreement with respect
to contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Investor, which consent shall not be unreasonably withheld; provided, further, however,
that the Investor shall only be liable under this Section 6.2 for that amount of a Claim or Indemnified Damages as does not exceed
the net proceeds to such Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified Party
and shall survive the resale of the Registrable Securities by the Investor pursuant to the Registration Statement. Notwithstanding
anything to the contrary contained herein, the indemnification agreement contained in this Section 6.2 with respect to any preliminary
prospectus shall not inure to the benefit of any Indemnified Party if the untrue statement or omission of material fact contained
in the preliminary prospectus were corrected on a timely basis in the prospectus, as then amended or supplemented. This indemnification
provision shall apply separately to each Investor and liability hereunder shall not be joint and several.

 

6.3              
Promptly after receipt by an Indemnified Person
or Indemnified Party under this Section 6 of notice of the commencement of any action or proceeding (including any governmental
action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party
shall, if a Claim in respect

    	 	8	 

    	 	 	 

    

thereof
is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a written notice of the commencement
thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory
to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be; provided, however, that an
Indemnified Person or Indemnified Party shall have the right to retain its own counsel with the fees and expenses to be paid by
the indemnifying party, if, in the reasonable opinion of counsel retained by the Indemnified Person or Indemnified Party, the
representation by counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due
to actual or potential differing interests between such Indemnified Person or Indemnified Party and any other party represented
by such counsel in such proceeding. The indemnifying party shall pay for only one (1) separate legal counsel for the Indemnified
Persons or the Indemnified Parties, as applicable, and such counsel shall be selected by the Investor, if the Investor is entitled
to indemnification hereunder, or the Company, if the Company is entitled to indemnification hereunder, as applicable. The Indemnified
Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with any negotiation or defense of
any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available
to the Indemnified Party or Indemnified Person which relates to such action or Claim. The indemnifying party shall keep the Indemnified
Party or Indemnified Person fully apprised at all times as to the status of the defense or any settlement negotiations with respect
thereto. No indemnifying party shall be liable for any settlement of any action, claim or proceeding affected without its written
consent, provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying
party shall, without the consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into
any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff
to such Indemnified Party or Indemnified Person of a release from all liability in respect to such Claim. Following indemnification
as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person
with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure
to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not
relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this Section 6, except to
the extent that the indemnifying party is prejudiced in its ability to defend such action.

 

6.4              
The indemnity agreements contained herein shall
be in addition to (I) any cause of action or similar right of the Indemnified Party or Indemnified Person against the indemnifying
party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.

 

SECTION
VII

CONTRIBUTION

 

7.1
To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make
the maximum contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent
permitted by law; provided, however, that: (I) no contribution shall be made under circumstances where the maker would not have
been liable for indemnification under the fault standards set forth in Section 6; (ii) no seller of Registrable Securities guilty
of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any
seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and (iii) contribution by any seller of Registrable
Securities shall be limited in amount to the net amount of proceeds received by such seller from the sale of such Registrable
Securities.

    	 	9	 

    	 	 	 

    

 

SECTION
VIII

REPORTS
UNDER THE 1934 ACT

 

8.1              
With a view to making available to the Investor
the benefits of Rule 144 promulgated under the 1933 Act or any other similar rule or regulation of the SEC that may at any time
permit the Investor to sell securities of the Company to the public without registration (“Rule 144”), provided that
the Investor holds any Registrable Securities are eligible for resale under Rule 144, the Company agrees to:

 

		a.	make
                                         and keep adequate current public information available, as those terms are understood
                                         and defined in Rule 144;

 

		b.	file
                                         with the SEC in a timely manner all reports and other documents required of the Company
                                         under the 1933 Act and the 1934 Act so long as the Company remains subject to such requirements
                                         (it being understood that nothing herein shall limit the Company’s obligations
                                         under Section 5(c) of the Equity Financing Agreement) and the filing of such reports
                                         and other documents is required for the applicable provisions of Rule 144; and

 

		c.	furnish
                                         to the Investor, promptly upon request, (I) a written statement by the Company that it
                                         has complied with the reporting requirements of Rule 144, the 1933 Act and the 1934 Act,
                                         (ii) a copy of the most recent annual or quarterly report of the Company and such other
                                         reports and documents so filed by the Company, and (iii) such other information as may
                                         be reasonably requested to permit the Investor to sell such securities pursuant to Rule
                                         144 without registration.

 

SECTION
X

MISCELLANEOUS

 

9.1               NOTICES.
Any notices or other communications required or permitted to be given under the terms of this Agreement that must be in
writing will be deemed to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by
facsimile (provided a confirmation of transmission is mechanically or electronically generated and kept on file by the
sending party); or (iii) one (1) day after deposit with a nationally recognized overnight delivery service, in each case
properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications shall be:

 

If
to the Company:

If
to the Company: Rich Pharmaceuticals, Inc.

Attn:
_______________

____________________

____________________

Fax:

With
a copy to: ____________________

Attn:

____________________

____________________

Fax:

 

    	 	10	 

    	 	 	 

    

 

If
to the Investor:GHS Investments, LLC

200
Stonehinge Lane,

Suite
3

Carle
Place, NY 11514

Fax:
(212) 574-3326

 

Each
party shall provide five (5) business days prior notice to the other party of any change in address, phone number or facsimile
number.

 

9.2              
NO WAIVERS.
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such
right or remedy, shall not operate as a waiver thereof.

 

 

9.3              
NO ASSIGNMENTS.
The rights and obligations under this Agreement shall not be assignable.

 

9.4              
ENTIRE AGREEMENT/AMENDMENT.
This Agreement and the Registered Offering Transaction Documents constitute the entire agreement among the parties hereto
with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or undertakings, other
than those set forth or referred to herein and therein. This Agreement and the Registered Offering Transaction Documents supersede
all prior agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof. The provisions
of this Agreement may be amended only with the written consent of the Company and Investor.

 

9.5              
HEADINGS. The headings in this Agreement
are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Whenever required by the context
of this Agreement, the singular shall include the plural and masculine shall include the feminine. This Agreement shall not be
construed as if it had been prepared by one of the parties, but rather as if all the parties had prepared the same.

 

9.6              
COUNTERPARTS. This Agreement may be executed
in any number of counterparts and by the different signatories hereto on separate counterparts, each of which, when so executed,
shall be deemed an original, but all such counterparts shall constitute but one and
the same instrument. This Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic
means with the same force and effect as if such signature page were an original thereof.

 

9.7              
FURTHER ASSURANCES. Each party shall do
and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other
agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

9.8              
SEVERABILITY. In case any provision of
this Agreement is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable, such
provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent possible, and the
validity and enforceability of the remaining provisions of this Agreement will not in any way be affected or impaired thereby.

 

9.9              
LAW GOVERNING THIS AGREEMENT.
This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard to
principles of conflicts of

    	 	11	 

    	 	 	 

    

laws.
Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought
only in the federal courts located in New York City, New York. The parties to this Agreement hereby irrevocably waive any objection
to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or
venue or based upon forum non conveniens. The parties executing this Agreement and other agreements referred to herein
or delivered in connection herewith on behalf of the Company agree to submit to the in personam jurisdiction of such courts and
hereby irrevocably waive trial by jury.  The prevailing party shall be entitled to recover from the other party its reasonable
attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection
herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative
to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such
provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other
provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served
in any suit, action or proceeding in connection with this Agreement or any other Registered Offering Transaction Documents by
mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law.

 

9.10          
NO THIRD
PARTY BENEFICIARIES. This Agreement is intended for the benefit
of the parties hereto and is not for the benefit of, nor may any provision hereof be enforced by, any other person, except that
the Company acknowledges that the rights of the Investor may be enforced by its general partner.

 

 

[Signature
page follows]

    	 	12	 

    	 	 	 

    

 

Your
signature on this Signature Page evidences your agreement to be bound by the terms and conditions of the Registration Rights Agreement
as of the date first written above. The undersigned signatory hereby certifies that he has read and understands the Registration
Rights Agreement, and the representations made by the undersigned in this Registration Rights Agreement are true and accurate,
and agrees to be bound by its terms.

 

GHS
INVESTMENTS, LLC

 

 

By:
/s/ Sarfraz Hajee

Name:
Sarfraz Hajee

Title:
Member

 

RICH
PHARMACEUTICALS, INC.

 

By:
/s/ Ben Chang

Ben
Chang, CEO 

 

 

 

[SIGNATURE
PAGE OF REGISTRATION RIGHTS AGREEMENT]

    	 	13PROMISSORY
NOTE 

 

Principal
Amount: $20,000.00

Date: February 21, 2017

 

FOR
VALUE RECEIVED, Rich Pharmaceuticals, Inc., a Nevada corporation ("Company"), promises to pay of GHS Investments,
LLC, a Nevada Limited Liability Company ("Holder"), or order, at Holder's place of business, the principal amount
of $20,000.00, with interest on such amount until paid, at the rate set forth below and payable pursuant to terms and conditions
contained herein. This Note is being issued as the commitment fee pursuant to the Equity Financing
Agreement executed between the Company and Holder on February 21, 2017.

 

INTEREST
RATE. The amount of outstanding principal shall bear interest at a rate of eight percent (8%) per annum. Interest shall accrue
on the principal balance from and after the date
hereof and shall be calculated on the basis of a 365-day year.

 

MAXIMUM
INTEREST. Notwithstanding the foregoing, in no event whatsoever shall the amount paid, or agreed to be paid, to Holder for
the use or forbearance of money to be loaned hereunder exceed the maximum amount permissible under applicable
law. If from any circumstance whatsoever
Holder shall receive as interest under this Note an amount that would exceed the highest
lawful rate, such amount that would be excessive interest shall be applied to the reduction of the principal amount owing
hereunder and not to the payment of interest, or if such excessive interest exceeds the unpaid balance of principal, such excess
shall be refunded to Company.

 

TERM.
The term of this Note shall be for a period beginning on the date hereof and ending on a date six (6) months from the date hereof
(the "Maturity Date"). All unpaid principal, together with any and all accrued and unpaid interest, shall be due on
the Maturity Date.

 

PAYMENT.
A payment of interest only shall be paid annually on each anniversary of the date of this Note. All outstanding principal and
interest shall be due and payable on the Maturity Date. Any payment hereunder shall be applied first to the payment of costs and
charges of collection, if any, then to accrued interest, and the balance, if any,
shall be then applied to reduction of principal. Principal and interest are payable in lawful money of the United States
of America.

 

PREPAYMENT.
Company may prepay this Note in full or in part at any time without a prepayment charge.

 

DEFAULT/ACCELERATION.
If any one or more of the following events shall occur (hereinafter called an "Event
of Default"), namely: (i) Company shall fail to make
timely payment of any payment hereunder and such failure is not cured within
five (5) business days of written notice by Holder to Company; or (ii) Company shall
become insolvent, or shall be unable to pay his debts as they mature; or shall admit in writing its inability to pay his debts
as they mature; or (iii) Company

    	 	1	 

    	 	 	 

    

shall
make an assignment for the benefit of his creditors, or shall file or commence, or have filed or commenced against him any proceeding
for any relief under any bankruptcy or insolvency law, or a receiver or trustee shall be appointed for Company;
THEN, upon the occurrence of any such
Event of Default, or upon the expiration of the term of this Note, Holder at its election, and without presentment, demand
or notice of any kind, all of which are expressly waived by Company, may declare the entire outstanding balance of principal and
interest thereon immediately due and
payable, together with all costs of collection, including attorneys' fees, in addition
to all of its other rights and remedies, all of which are cumulative.

 

NO
WAIVER BY HOLDER. The acceptance by Holder of any payment under this Note after the date such payment is due, or the failure
to declare an Event of Default as herein provided, shall not constitute a waiver of any of the terms of this Note or the right
to require the prompt payment when due of future or succeeding payments or to declare an Event of Default
for any failure to so pay or for any other default. The acceptance by Holder of a payment of a portion of any installment
at any time that such installment is due in full shall not cure or excuse the default caused by the failure to pay such installment
in full and shall not constitute a waiver of the right to require full payment when due of all future or succeeding installments.

 

ATTORNEYS'
FEES AND COSTS. In the event Holder takes any action to enforce any provision
of this Note, either through legal proceedings or otherwise, Company promises to immediately reimburse Holder for reasonable attorneys'
fees and all other costs and expenses so incurred as awarded by a court of law. Company shall also reimburse Holder for all attorneys'
fees and costs reasonably incurred in the representation of Holder in any bankruptcy, insolvency, reorganization or other debtor-relief
proceeding of or relating to Company.

 

WAIVERS.
Company and any endorsers, guarantors and sureties of this Note hereby waive diligence, demand, presentment, notice of nonpayment,
protest and notice of protest and expressly agree that this Note and any payment hereunder may be renewed, modified or extended
from time to time and at any time and consent to the acceptance or release of security for this Note or a release of any party
or guarantor, all without in any way affecting their liability and waive the right to plead any and all statutes of limitations
as a defense to any demand on this Note, or on any guaranty thereof, or to any agreement to pay the same to the full extent permissible
by law.

 

MISCELLANEOUS.
The terms of this Note shall inure to the benefit of and bind the parties hereto
and their successors and assigns. Company represents and warrants to Holder that the obligations hereunder arise out of or in
connection with business purposes and do not relate to any personal, family or household purpose. As used herein the term "Company"
shall include the undersigned Company and any other person or entity who may subsequently become liable for the payment hereof.
The term "Holder" shall include the named Holder as well as any other person or entity to whom this Note or any interest
in this Note is conveyed, transferred or assigned. Each person signing this Note on behalf of Company represents and warrants
that he has full authority to do so and that this Note binds Company.

    	 	2	 

    	 	 	 

    

GOVERNING
LAW. This Note shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada
without giving any effect to principles of conflict of laws.

 

 

Rich
Pharmaceuticals, Inc.

 

/s/
Ben Chang

By:
Ben Chang, CEO

    	 	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]